Thank you for sharing!

Your article was successfully shared with the contacts you provided.

When Eli Lilly & Co. announced its $6 billion acquisition of Imclone Systems in the fall of 2008–its biggest deal ever–the financial markets were collapsing and the outside funds in which Lilly had invested a portion of its cash were falling right along with them. Thomas Grein, treasurer and vice president of the Indianapolis-based pharmaceutical company, which had net income of $2.6 billion on $11.2 billion of revenue in the first half of 2010, says the company first started hiring outside managers in 2000. They provided Lilly with some additional returns in the first part of the decade, but the credit crunch of 2008 was less kind, he says, and one manager was especially troublesome.

Treasury & Risk

Join Treasury & Risk

Don’t miss crucial treasury and finance news along with in-depth analysis and insights you need to make informed treasury decisions. Join Treasury & Risk now!

  • Free unlimited access to Treasury & Risk including case studies with corporate innovators, informative newsletters, educational webcasts, and resources from industry leaders.
  • Exclusive discounts on ALM and Treasury & Risk events.
  • Access to other award-winning ALM publications including PropertyCasualty360.com and Law.com.

Already have an account? Sign In Now
Join Treasury & Risk

Copyright © 2019 ALM Media Properties, LLC. All Rights Reserved.